Moreover, in TNF-α-stimulated NHKs, the secretion of TGF-β is incremented by tacrolimus and, conversely, the expression of inducible nitric oxide synthase (iNOS) is downregulated, which probably is associated with its therapeutic efficacy in the treatment of AD [272]. This evidence concerns the gene NOS2 and Alzheimer disease.